NCT00338104 - Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

HyperglycemiaDiabetes

Interventions

DRUG

insulin glargine

Insulin glargine given at 40% of prior stable drip rate.

DRUG

insulin glargine

Insulin glargine given at 60% of prior stable drip rate.

DRUG

insulin glargine

Insulin glargine given at 80% of prior stable drip rate.

Trial Locations (1)

Northwestern Memorial Hospital, Chicago